ANRO

ALTO NEUROSCIENCE INC

ANRO·02157Q109·US·Common Stock·Healthcare - Biotechnology-13D/G

ANRO (ALTO NEUROSCIENCE INC) is held by 68 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($27.1M), FRANKLIN RESOURCES INC ($24.8M), MILLENNIUM MANAGEMENT LLC ($18.5M). Net institutional sentiment: Mixed.

68
Holders
(4 Elite)
$208.7M
Total Value
51% (67)
Consensus
34 buying - 33 selling
13F: Insider & Congress:
ANROSmart Money Verdict
View all
Held by 68 funds
4 elite
Who's Trading
ActivistCOCommodore Capital LP9.9%May 15, 2026
ActivistSISirenia Capital Management LP7.9%May 15, 2026
ActivistSteven A. CohenSteven A. Cohen3.7%May 15, 2026
ActivistVPVestal Point Capital, LP6.5%May 15, 2026
ActivistARArmistice Capital, LLC4.9%Feb 18, 2026
ActivistPAPerceptive Advisors LLC10.0%Feb 17, 2026
ActivistARArmistice Capital, LLC6.0%Feb 17, 2026
ActivistKHK2 HealthVentures Equity Trust LLC2.4%Feb 17, 2026
ActivistBlackRock, Inc.BlackRock, Inc.2.1%Jul 16, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
1.2M$27.1M0.0%+31.68%
40
Decreased
1.1M(-1.6%)$24.8M0.0%+92.39%
0
Increased
821,982(+30.5%)$18.5M0.0%+112.37%
36
Increased
666,188(+9.6%)$15M0.0%+151.17%
31
Decreased
503,087(-68.7%)$11.3M0.0%+132.02%
0
Increased
486,726(+44.5%)$10.9M0.1%+42.30%
38
Decreased
473,403(-0.2%)$10.6M0.0%+266.92%
0
New
386,426$8.7M0.0%+31.68%
38
New
385,000$8.7M0.0%+31.68%
38
Increased
371,208(+1128.0%)$8.3M0.0%+35.52%
44
Increased
292,899(+1.9%)$6.6M0.0%+104.17%
28
Increased
238,498(+101.8%)$5.4M0.0%+121.18%
44
Decreased
227,101(-52.4%)$5.1M0.0%+147.71%
0
Increased
216,099(+54.0%)$4.9M0.0%+130.95%
38
Increased
209,268(+85.5%)$4.7M0.0%+39.81%
42
Increased
199,503(+52.7%)$4.5M0.0%+84.09%
38
Decreased
176,347(-8.7%)$4M0.0%+562.40%
0
New
165,272$3.7M0.0%+31.68%
37
Decreased
104,717(-33.0%)$2.4M0.0%+176.54%
0
Increased
103,499(+6.3%)$2.3M0.0%+262.75%
28

Showing 1-20 of 70

1 / 4

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used